Fundraising Fox
/Companies
Sign in

Valora Therapeutics

La Jolla, US · Founded 2023 · 19 employees on LinkedIn · 3 known investors

Find your way into Valora Therapeutics

Sign up to see every warm intro you have to Valora Therapeutics

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the Valora Therapeutics team. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Sign up with GoogleAlready have an account? Log in

Valora Therapeutics is a biotech company developing antibody-lectin chimera (AbLec) therapeutics that target cell-surface glycans for immuno-oncology and immunotherapy applications. Its work builds on glycobiology and bioorthogonal chemistry research.

BiotechHealthtech

Founders & leadership

Valora Therapeutics was founded in 2023 by Miguel Garcia-Guzman, Carolyn Bertozzi, and Jessica Stark.

MGMiguel Garcia-Guzman
Miguel Garcia-GuzmanCo-Founder, CEO & DirectorDirector at Rakuten Med
CBCarolyn Bertozzi
Carolyn BertozziScientific Co-Founder
JSJessica Stark
Jessica StarkScientific Co-Founder
JLJames Lee
James LeeVP, Business DevelopmentJames Lee has over 15 years of experience in biotech and pharmaceutical business development and R&D across oncology and other therapeutic areas. He holds a bachelor's degree in bioengineering and a master's degree in molecular biotechnology from the University of Pennsylvania, and an MBA from Columbia Business School.

Board

SH
Stefan HellerBoard director
SMSanford Madigan
Sanford MadiganDirectorManaging Partner at Avalon BioVentures

Investors · 3

Correlation Ventureslisted by Correlation VenturesSan Francisco · $100K – $4M

How we know: Correlation Ventures's portfolio page · press coverage · Not right? Tell us

AlexandriareportedPasadena

How we know: press coverage · Not right? Tell us

Reported raises · per SEC filings

Form D private placements

$13M disclosed across 1 round · 2024

▶$13MraisedJul 2024 · 12 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Miguel Garcia-GuzmanExecutive Officer, Director
  • Stefan HellerDirector
  • Sanford MadiganDirector
Offering amount
$29.2M
Amount sold
$13M
First sale
Jul 2024
Incorporated
Corporation, Delaware, 2023
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

In the news

Sell or Invest in Valora Therapeutics Stock Pre-IPOnasdaqprivatemarket.com · Nov 2025Valora Therapeutics Raises $30 Million Seed Financing — Valora Therapeuticsvaloratherapeutics.com · Nov 2024

Frequently asked questions

What does Valora Therapeutics do?
Valora Therapeutics is a biotech company developing antibody-lectin chimera (AbLec) therapeutics that target cell-surface glycans for immuno-oncology and immunotherapy applications. Its work builds on glycobiology and bioorthogonal chemistry research.
Who founded Valora Therapeutics?
Valora Therapeutics was founded by Miguel Garcia-Guzman, Carolyn Bertozzi, Jessica Stark in 2023.
Who are Valora Therapeutics's investors?
Valora Therapeutics's investors include Avalon BioVentures, Correlation Ventures, Alexandria.
How much funding has Valora Therapeutics raised?
Valora Therapeutics has disclosed $13M raised across 1 round.
Where is Valora Therapeutics headquartered?
Valora Therapeutics is headquartered in La Jolla, US.